跳至主要内容
临床试验/NCT04077034
NCT04077034已完成不适用

A Randomized, Parallel, Double Blind, Placebo Controlled Clinical Study Evaluating the Effect of Probiotic Formula on Immune System in Preschool Children

Deerland Enzymes10 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2019年4月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
102
试验地点
10
主要终点
The incidence of gastrointestinal and/or respiratory infections for experimental group compared to control group

研究概览

简要总结

Healthy preschool children will be recruited, gastrointestinal infection and respiratory infection symptoms will be followed during the 8-week treatment and 4-week follow-up period, to evaluate the effect of the used probiotic formula on immune system in comparison to the group using placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
2 Years 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • signed informed consent by at least one parent or legal guardian
  • children aged 2 to 6 years
  • attending or about to start attending day-care

排除标准

  • body weight at birth <2500g
  • gestational age <37 weeks
  • severe chronic illness
  • regular use of medication
  • immunodeficiency
  • parent or legal guardian not able to understand and comply with requirements of the study

研究组 & 干预措施

Experimental group

Experimental

Probiotic DE111®

干预措施: Probiotic Formula Bacillus subtilis DE111® (Dietary Supplement)

Control group

Placebo Comparator

Placebo

干预措施: Placebo comparator (Dietary Supplement)

结局指标

主要结局

The incidence of gastrointestinal and/or respiratory infections for experimental group compared to control group

时间窗: 12-week study period (consisting of 8-week treatment plus 4-week follow-up)

Number of participants with at least one occurrence of gastrointestinal and/or respiratory infections during 12-week study period in the experimental group compared to control group.

The incidence of adverse events occuring in the experimental group compared to control group

时间窗: 12-week study period (consisting of 8-week treatment plus 4-week follow-up)

Number of participants with treatment related adverse events during 12-week study period for both, experimental and control group.

次要结局

未报告次要终点

研究者

发起方
Deerland Enzymes
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验